Elekta (OTCMKTS:EKTAY) Shares Gap Down – Time to Sell?

Shares of Elekta AB (OTCMKTS:EKTAY) gapped down before the market opened on Wednesday . The stock had previously closed at $5.5599, but opened at $5.00. Elekta shares last traded at $5.00, with a volume of 2,722 shares.

Analysts Set New Price Targets

Separately, Zacks Research cut Elekta from a “hold” rating to a “strong sell” rating in a research report on Tuesday, June 2nd. Two research analysts have rated the stock with a Sell rating, Based on data from MarketBeat, Elekta presently has a consensus rating of “Sell”.

Elekta Trading Down 7.7%

The firm has a 50-day moving average of $5.94 and a 200-day moving average of $6.08. The company has a debt-to-equity ratio of 0.56, a quick ratio of 0.73 and a current ratio of 0.95. The firm has a market capitalization of $1.86 billion, a P/E ratio of -31.50 and a beta of 1.00.

Elekta (OTCMKTS:EKTAY) last released its quarterly earnings results on Thursday, May 28th. The company reported $0.06 EPS for the quarter. The business had revenue of $521.00 million during the quarter. Elekta had a positive return on equity of 10.67% and a negative net margin of 3.32%. On average, equities research analysts anticipate that Elekta AB will post 0.43 EPS for the current fiscal year.

Elekta Company Profile

Elekta is a global medical technology company specializing in the development, manufacture and support of precision radiation therapy and radiosurgery equipment. Its products and services aim to improve patient outcomes in oncology and neurosurgery by combining advanced hardware, software and clinical workflow solutions. Elekta’s offerings are designed to address a broad range of cancer types and brain disorders through targeted, image-guided treatments.

The company’s core product portfolio includes linear accelerators for external beam radiation therapy, stereotactic radiosurgery systems such as the renowned Gamma Knife platform, and brachytherapy solutions for internal radiation treatment.